Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.
PMID 41564866 · PMC12866162 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
CHD1 and MAP3K7 loss additively sensitizes cancer cells to IFN-γ-induced death
-
Full-text index only
Integrating natural and engineered genetic variations to decode regulatory influence on blood traits.
PMID 41637188 · PMC12932927 · Cell reports · 2026 · 8 claims · 8 setups
Combined MPRA enhancer assays, RNA-seq (DE/ATU) analysis, and CRISPR-Cas9 engineering to dissect the function of 94 rare non-coding variants (RNVs) associated with blood traits
-
Full-text index only
scLong: a billion-parameter foundation model for capturing long-range gene context in single-cell transcriptomics.
PMID 41639087 · PMC12982784 · Nature communications · 2026 · 7 claims · 4 setups
scLong performs self-attention across all ~27,874 human genes, including lowly expressed ones, to capture long-range gene dependencies missed by models restricted to highly expressed gene subsets
-
Full-text index only
Functional germline variants together with somatic mutations alter the integrity of cancer hallmark regulatory networks.
PMID 42057121 · PMC13151107 · Genome medicine · 2026 · 8 claims · 6 setups
Combined germline and somatic alterations disturb cancer hallmark pathway integrity in individual-specific ways, potentially explaining unique clinical behavior of each cancer.